Yoko Kidani

1.9k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Yoko Kidani is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yoko Kidani has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yoko Kidani's work include Immune Cell Function and Interaction (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cardiac Arrhythmias and Treatments (5 papers). Yoko Kidani is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Cardiac Arrhythmias and Treatments (5 papers). Yoko Kidani collaborates with scholars based in Japan, United States and Czechia. Yoko Kidani's co-authors include Steven J. Bensinger, Takumi Taniguchi, Hiroko Kanakura, Ken Yamamoto, Yasuhiko Takemoto, Heidi Elsaesser, Elizabeth Wilson, David G. Brooks, M. Benjamin Hock and Timothy F. Osborne and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and Nature Immunology.

In The Last Decade

Yoko Kidani

25 papers receiving 1.3k citations

Hit Papers

Sterol regulatory element–binding proteins are essential ... 2013 2026 2017 2021 2013 100 200 300 400

Peers

Yoko Kidani
Christa Booy Switzerland
Gilbert R. Kinsey United States
Brian S. Cain United States
Siamak Djafarzadeh Switzerland
Christa Booy Switzerland
Yoko Kidani
Citations per year, relative to Yoko Kidani Yoko Kidani (= 1×) peers Christa Booy

Countries citing papers authored by Yoko Kidani

Since Specialization
Citations

This map shows the geographic impact of Yoko Kidani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Kidani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Kidani more than expected).

Fields of papers citing papers by Yoko Kidani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Kidani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Kidani. The network helps show where Yoko Kidani may publish in the future.

Co-authorship network of co-authors of Yoko Kidani

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Kidani. A scholar is included among the top collaborators of Yoko Kidani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Kidani. Yoko Kidani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Takahara, Mitsuyoshi, Tomoya Mita, Naoto Katakami, et al.. (2021). Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER. Diabetes Therapy. 13(2). 251–264. 5 indexed citations
4.
Miyamoto, Susumu, Takanori Ikeda, Satoshi Ogawa, et al.. (2020). Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan. Journal of Stroke and Cerebrovascular Diseases. 29(4). 104584–104584. 8 indexed citations
5.
Murakawa, Yuji, Takanori Ikeda, Satoshi Ogawa, et al.. (2020). Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation. Heart and Vessels. 35(8). 1125–1134. 9 indexed citations
6.
Ikeda, Takanori, Satoshi Ogawa, Takanari Kitazono, et al.. (2019). Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings. Journal of Thrombosis and Thrombolysis. 48(4). 653–660. 45 indexed citations
7.
Nakagawara, Jyoji, Takanori Ikeda, Satoshi Ogawa, et al.. (2019). Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal function. Journal of Cardiology. 74(6). 501–506. 1 indexed citations
8.
Minematsu, Kazuo, Takanori Ikeda, Satoshi Ogawa, et al.. (2019). Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack. Cerebrovascular Diseases. 48(1-2). 53–60. 4 indexed citations
9.
Kitazono, Takanari, Takanori Ikeda, Satoshi Ogawa, et al.. (2019). Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation. Heart and Vessels. 35(3). 399–408. 7 indexed citations
10.
Kidani, Yoko & Steven J. Bensinger. (2017). Reviewing the impact of lipid synthetic flux on Th17 function. Current Opinion in Immunology. 46. 121–126. 16 indexed citations
11.
Palumbo, Tiziana, Kojiro Nakamura, Charles Lassman, et al.. (2016). Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model. Transplantation. 101(2). 322–331. 27 indexed citations
12.
Nakano, Yusuke, Yoko Kidani, S. Furue, et al.. (2016). Role of Prostaglandin D2 and DP1 Receptor on Japanese Cedar Pollen-Induced Allergic Rhinitis in Mice. Journal of Pharmacology and Experimental Therapeutics. 357(2). 258–263. 3 indexed citations
13.
Kidani, Yoko, Heidi Elsaesser, M. Benjamin Hock, et al.. (2013). Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nature Immunology. 14(5). 489–499. 419 indexed citations breakdown →
14.
Wilson, Elizabeth, Yoko Kidani, Heidi Elsaesser, et al.. (2012). Emergence of Distinct Multiarmed Immunoregulatory Antigen-Presenting Cells during Persistent Viral Infection. Cell Host & Microbe. 11(5). 481–491. 47 indexed citations
15.
Kidani, Yoko & Steven J. Bensinger. (2012). Liver X receptor and peroxisome proliferator‐activated receptor as integrators of lipid homeostasis and immunity. Immunological Reviews. 249(1). 72–83. 164 indexed citations
16.
Hong, Cynthia, Yoko Kidani, Noelia A-González, et al.. (2011). Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. Journal of Clinical Investigation. 122(1). 337–347. 116 indexed citations
17.
Kidani, Yoko, et al.. (2006). Which Is a Better Position for Insertion of a High Thoracic Epidural Catheter: Sitting or Lateral Decubitus?. Journal of Cardiothoracic and Vascular Anesthesia. 20(5). 656–658. 12 indexed citations
18.
Kidani, Yoko, et al.. (2005). Sevoflurane Pretreatment Inhibits Endotoxin-Induced Shock in Rats. Anesthesia & Analgesia. 101(4). 1152–1156. 15 indexed citations
19.
Taniguchi, Takumi, Yoko Kidani, Hiroko Kanakura, Yasuhiko Takemoto, & Ken Yamamoto. (2004). Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Critical Care Medicine. 32(6). 1322–1326. 224 indexed citations
20.
Taniguchi, Takumi, Y. Takemoto, Hiroko Kanakura, Yoko Kidani, & Ken Yamamoto. (2003). The Dose-Related Effects of Ketamine on Mortality and Cytokine Responses to Endotoxin-Induced Shock in Rats. Anesthesia & Analgesia. 97(6). 1769–1772. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026